Summary
The FDA is seeking research proposals under an R01 mechanism to support efficient and innovative natural history studies that address unmet needs in rare diseases. Clinical trials are optional under this funding opportunity. The intent is to advance scientific understanding of rare disease progression and inform future drug development and regulatory decision-making. This is a forecasted opportunity, meaning full solicitation details have not yet been released.
